Therapeutic effects of physostigmine during systemic inflammation
Katharina Effenberger-Neidnicht,1 Johannes Jägers,2 Rabea Verhaegh,1 Michael Kirsch1 1Institute of Physiological Chemistry, University Hospital Essen, Essen, Germany; 2Institute of Physiology, University Hospital Essen, Essen, Germany Introduction: Usually, physostigmine is used as antidote...
Guardado en:
Autores principales: | Effenberger-Neidnicht K, Jägers J, Verhaegh R, Kirsch M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c9c7f94bbb89450a839cbe4c6d2aba92 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Moderate glucose supply reduces hemolysis during systemic inflammation
por: Jägers J, et al.
Publicado: (2018) -
Microvascular stasis and hemolysis: coincidence or causality?
por: Effenberger-Neidnicht K, et al.
Publicado: (2019) -
Screening of Key Genes of Sepsis and Septic Shock Using Bioinformatics Analysis
por: Zeng X, et al.
Publicado: (2021) -
PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis
por: Wasyluk W, et al.
Publicado: (2021) -
Circulating Neutrophil-Derived Microparticles Associated with the Prognosis of Patients with Sepsis
por: Chen HP, et al.
Publicado: (2020)